Hospital del Mar Research Institute Hospital del Mar Research Institute

Integrated and Translational Pharmacy Pau Riera

The Integrated and Translational Pharmacy Research Group advances clinical pharmacy practice through real-world evidence, pragmatic research, pharmacometrics, and artificial intelligence.

Our mission is to translate research into safer, more effective, and more personalized pharmacotherapy across pharmaceutical care, clinical nutrition, oncohematology, pharmacogenomics, and antimicrobial stewardship.

We collaborate with multidisciplinary teams and research networks, and we train the next generation of clinical researchers through mentorship and methodology support.

Research lines

The group's scientific activity focuses on the following research lines, summarised below:

  • Pharmaceutical care for outpatients receiving hospital-dispensed medicines (MHDA): research aimed at improving pharmaceutical care for outpatients treated with hospital-dispensed medicines (MHDA). This includes pharmacotherapeutic monitoring, medication adherence, treatment safety and effectiveness, as well as improving the patient experience.
  • Pharmaceutical care in chronic conditions, frailty and mental health: development of pharmaceutical care strategies tailored to patients with chronic diseases, frailty and mental health conditions. This research focuses on medication review and optimisation, the prevention of drug-related problems and continuity of care.
  • Organisational management, healthcare process redesign, quality of care and medicines policy: research aimed at improving organisational models and healthcare pathways, assessing the quality and safety of care, optimising resource efficiency, and evaluating and managing medicines policy.
  • Pharmacogenetics, Oncology-Haematology, Clinical Trials and Drug Preparation: research into personalised treatments through pharmacogenetics, the optimisation of pharmacotherapy in oncohaematology, the development and monitoring of clinical trials, and the quality and safety of drug preparation processes.
  • Artificial Intelligence / Emergency Medicine / Critically Ill Patients: application of artificial intelligence and data analysis tools to improve clinical decision-making, optimise treatments and develop predictive models, particularly in emergency medicine and the care of critically ill patients.
  • Antimicrobial Stewardship Programmes (PROA) / Infectious Diseases: development and evaluation of strategies to optimise antimicrobial use, improve the appropriateness of anti-infective treatments, and contribute to the prevention of antimicrobial resistance and the improvement of clinical outcomes.

These research lines share a translational approach based on scientific evidence, real-world clinical research, pharmacometrics and methodological innovation, with the aim of translating research findings into clinical practice.

Contact

Coordinator:
Pau Riera(ELIMINAR)

Tel:
93 248 31 06

Passeig Marítim, 25-29
08003 Barcelona

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact